The drug, called dapagliflozin, was previously only available to NHS patients with one of the three types of heart failure – representing roughly half of the million people in the UK living with the incurable condition. The Daily Mail
Monday 22 May 2023
Breakthrough daily diabetes tablet to treat all British heart failure sufferers secures NHS approval
Breakthrough daily diabetes tablet to treat all British heart failure sufferers secures NHS approval All British heart failure sufferers will now be eligible for a breakthrough daily tablet that dramatically reduces symptoms and boosts survival chances.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment